Results 261 to 270 of about 83,570 (294)
Some of the next articles are maybe not open access.
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design, 2012Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to prominence particularly because of its ability to cause infections in immunocompromised patients.
Evans, Benjamin A. +2 more
openaire +3 more sources
[Carbapenem resistance in enterobacteria].
Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2009Carbapenems are the drugs of choice in the treatment of serious infections caused by multiresistant Gram-negative bacteria. Clinically and epidemiologically, resistance to these beta-lactams poses the highest risk. In enterobacteria, two common mechanisms can cause the resistance to carbapenems: (1) hydrolysis of carbapenems by beta-lactamases and (2 ...
J, Hrabák, E, Chudácková
openaire +1 more source
Screening for carbapenem-resistant bacteria
The Lancet Infectious Diseases, 2005James S, Soothill, Paul E, Lock
openaire +2 more sources
Carbapenem-resistant Enterobacterales in the USA
The Lancet Infectious Diseases, 2020Sumanth, Gandra, Carey-Ann D, Burnham
openaire +2 more sources
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae
Nature Medicine, 2020Christoph M Ernst +2 more
exaly
Carbapenem-resistant Enterobacteriaceae: global action required
The Lancet Infectious Diseases, 2019Federico, Perez, Robert A, Bonomo
openaire +2 more sources